日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor

药物再利用筛选确定 lonafarnib 为呼吸道合胞病毒融合蛋白抑制剂

Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen Johnson, Kaycie Morwood, Katharina Rox, Wal

Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets

重新利用筛选可确定广谱冠状病毒抗病毒药物的新候选药物和可用药宿主靶点

Sibylle Haid #, Alina Matthaei #, Melina Winkler #, Svenja M Sake, Antonia P Gunesch, Vanessa Milke, Natalie M Köhler, Jessica Rückert, Gabrielle Vieyres, David Kühl, Tu-Trinh Nguyen, Matthias Göhl, Lisa Lasswitz, Francisco J Zapatero-Belinchón, Graham Brogden, Gisa Gerold, Bettina Wiegmann, Ursula

Landscape of protein-protein interactions during hepatitis C virus assembly and release

丙型肝炎病毒组装和释放过程中蛋白质 - 蛋白质相互作用的概况

Alina Matthaei #, Sebastian Joecks #, Annika Frauenstein #, Janina Bruening, Dorothea Bankwitz, Martina Friesland, Gisa Gerold, Gabrielle Vieyres, Lars Kaderali, Felix Meissner, Thomas Pietschmann

The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection

人类肝脏表达的凝集素 CD302 可限制丙型肝炎病毒感染

Birthe Reinecke, Nicola Frericks, Chris Lauber, Katja Dinkelborg, Alina Matthaei, Florian W R Vondran, Patrick Behrendt, Sibylle Haid, Richard J P Brown, Thomas Pietschmann